ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
This test is inexpensive and results are available immediately as compared to the genetic test
The initiative will engage adolescents and youth of India in decisions about their reproductive health
Carestream equipment is highly recommended for its imaging quality
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Evidence also shows better immune response to virus among users of spray
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Subscribe To Our Newsletter & Stay Updated
